SCHEMBL4159049

SCHEMBL4159049

CN(C(=O)c1c(F)cccc1F)C(=O)N(C)c1ccc(SC(F)(F)F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 1/20 0.39
TDP1 Q9NUW8 3/20 0.38
RORC P51449 1/20 0.35
ALDH1A1 P00352 2/20 0.34
GPBAR1 Q8TDU6 2/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
POLB P06746 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
KIF11 P52732 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
KCNK2 O95069 1/20 0.32
KCNK10 P57789 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
PTPRZ1 P23471 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4150870 0.89 RORC (0.39) TLR7TDP1RORCGPBAR1NR1H2
SCHEMBL4150864 0.87 TDP1 (0.41) TLR7TDP1RORCGPBAR1NR1H2
SCHEMBL4154435 0.84 RORC (0.36) TLR7TDP1RORCGPBAR1CES2
SCHEMBL4156749 0.84 POLB (0.37) TLR7TDP1RORCALDH1A1GPBAR1
SCHEMBL4149997 0.82 RORC (0.41) TLR7TDP1RORC
SCHEMBL4155292 0.82 RORC (0.38) TLR7TDP1RORCGPBAR1POLB
SCHEMBL4912606 0.80 GPBAR1 (0.49) TLR7TDP1RORCGPBAR1CES2
SCHEMBL4150579 0.79 TLR7 (0.39) TLR7TDP1TRPV1KIF11SMN1; SMN2
SCHEMBL4159052 0.79 TDP1 (0.37) TLR7TDP1RORCALDH1A1GPBAR1
SCHEMBL4162997 0.77 RORC (0.46) TLR7RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 TLR7 905/4885TDP1 1690/4885RORC 4448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.